ShinNippon Agrees Licensing Nasal Drug Delivery Technology to Tokai Pharmaceuticals.Tokyo, Japan, Aug 4, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - ShinNippon Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Laboratories' two subsidiaries, Translational Research Ltd.(TRL TRL In currencies, this is the abbreviation for the Turkish Lira. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ) and Bioactis Ltd. have signed general terms of agreement for the licensing and supplying of their patented nasal drug delivery technology in the field of endocrinology endocrinology Medical discipline dealing with regulation of body functions by hormones and other biochemicals and treatment of endocrine system imbalances. In 1841 Friedrich Gustav Henle first recognized “ductless glands,” which secrete products directly into to Tokai Pharmaceuticals of Massachusetts, USA. The nasal drug delivery systems developed by TRL is an injection delivered through the nasal membrane such as insulin for diabetes and morphine morphine, principal derivative of opium, which is the juice in the unripe seed pods of the opium poppy, Papaver somniferum. It was first isolated from opium in 1803 by the German pharmacist F. W. A. for painkiller. Nasal delivery has attracted attention for its high safety feature without causing any irritation in patients. Bioactis has been developing nasal devices which are user friendly to patients and has highly effective spraying performance. The combination of TRL's nasal technology with quality delivery device is intended to create an effective therapeutic package for improving the patient's quality of life. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion